<?xml version="1.0" encoding="UTF-8"?>
<p>The localization and identification of 
 <italic>α</italic>-synuclein mutations as a cause of PD in the mid 1990’s was perhaps the first concrete and revolutionary finding in PD genetics [
 <xref rid="ref001" ref-type="bibr">1</xref>]. This came about as a result of the intuition and hard work of a clinical team from New Jersey, followed by the linkage and positional cloning efforts of a genetic team at NIH, orchestrated by the then director of NINDS, Zach Hall. This effort (described by Bob Nussbaum in another article in this issue) was an extraordinary success.
</p>
